Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935088 · ClinicalTrials.gov registry record
PRESSUREwire Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,217
- Enrollment target
NCT02935088 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,217 participants.
The verdict
NCT02935088 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,217 participants
- Enrollment target
Study Summary
The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.
Interventions
- DEVICE Fractional Flow Reserve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,217 participants |
| Start Date | 2016-10-12 |
| Est. Completion | 2019-03-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02935088
The ClinicalTrials.gov registry entry for NCT02935088 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fractional Flow Reserve is the first listed.
NCT02935088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02935088 about?
NCT02935088 is a clinical study titled "PRESSUREwire Study". The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting wi...
What is the current status of trial NCT02935088?
This trial is currently completed. The enrollment target is 2,217 participants. The study started on 2016-10-12. Estimated completion is 2019-03-22.
What interventions are being tested in trial NCT02935088?
The interventions under investigation include: Fractional Flow Reserve (DEVICE).
Who is sponsoring clinical trial NCT02935088?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.